Implantable biodegradable polymers for IUdR radiosensitization of experimental human malignant glioma

Journal of Neuro-Oncology

Volumn 32, Issue 3, 1997, Pages 181-192

  Williams, Jeffery A ^a,b   Dillehay, Larry E ^a   Tabassi, Kevin ^b   Sipos, Eric ^b   Fahlman, Christian ^a   Brem, Henry ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Biodegradable polymer; Human glioma; Iododeoxyuridine; Radiosensitization

Indexed keywords

GLUCOSE; IDOXURIDINE; POLYANHYDRIDE; POLYMER; SEBACIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CELL SURVIVAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; GLIOBLASTOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; RADIATION DOSE; RADIOSENSITIZATION; SUBCUTANEOUS DRUG ADMINISTRATION; XENOGRAFT;

ANIMALS; BIODEGRADATION, ENVIRONMENTAL; BRAIN NEOPLASMS; DECANOIC ACIDS; DRUG IMPLANTS; GLIOMA; HUMANS; IDOXURIDINE; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RADIATION-SENSITIZING AGENTS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0031040208     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005704913330     Document Type: Article

References (51)

1. Kornblith PL, Walker M: Chemotherapy for malignant gliomas. J Neurosurg 68: 1-17, 1988
2. Chang C, Horton J, Schoenfeld D, Salazar O, Perez-Tamayo R, Kramer S, Weinstein A, Nelson J, Tsjkada Y: Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint radiation therapy oncology group and eastern cooperative oncology group study. Cancer 52(6): 997-1007, 1983
3. Walker MD, Strike TA, Sheline GE: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg 49: 333-343, 1978
4. Walker MD, Strike TA, Sheline GE: An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 5: 1725-1731, 1979
5. Curran WJ, Scott CB, Nelson JS: Survival comparison of radiosurgery eligible and ineligible malignant glioma patients treated with hyperfractionated radiation therapy and BCNU: A report of RTOG 83-02. J Clin Oncol 11: 857-862, 1993
6. Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, Isaacson S, Rotman M, Asbell S, Nelson J, Weinstein A, Nelson D: Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive radiation therapy oncology group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 26: 239-244, 1993
7. Hochberg FH, Pruitt A: Assumptions in the radiotherapy of glioblastoma. Neurology 30: 907-911, 1980
8. Bashir R, Hochberg F, Oot R: Regrowth patterns of glioblastoma multiforme related to planning of interstitial brachytherapy radiaton fields. Neurosurgery 23: 27-30, 1988
9. Wallner K, Galicich J, Krol G, Arbit E, Malkin M: Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 16: 1405-1409, 1989
10. Uhl V, Phillips T, Ross G, Bodell W, Rasmussen J: Iododeoxyuridine incorporation and radiosensitization in three human tumor cell lines. Int J Radiat Oncol Biol Phys 22: 489-494, 1992
11. McLaughlin PW, Lawrence TS, Seabury H, Nguyen N, Stetson PL, Greenberg HS, Mancini WR: Bromodeoxyuridine-mediated radiosensitization in human glioma: the effect of concentration, duration, and fluoropyrimidine modulation. Int J Radiat Oncol Biol Phys 30(3): 601-607, 1994
12. Erickson R, Szybalski W: Molecular radiobiology of human cell lines. V. Comparative radiosensitizing properties of 5-halodeoxycytidines and 5-halodeoxyuridines. Radiat Res 20: 252-262, 1963
13. Fornace AJ, Dobson PP, Kinsella TJ: Enhancement of radiation damage in cellular DNA following unifilar substitution with iododeoxyuridine. Int J Radiat Oncol, Biol Phys 18: 873-878, 1990
14. Uhl V, Phillips T, Ross G, Bodell W, Rasmussen J: Iododeoxyuridine incorporation and radiosensitization in three human tumor cell lines. Int J Radiat Oncol, Biol Phys 22: 489-494, 1992
15. Levin VA, Prados MR, Wara WM, Davis RL, Gutin PH, Phillips TL, Lamborn K, Wilson CB: Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas. Int J Radiat Oncol Biol Phys 32(1): 75-83, 1995
16. Djordjevic B, Szybalsi W: Genetics of human cell lines. III. Incorporation of 5-bromo- and 5-iododeoxyuridine into deoxyribonucleic acid of human cells and its effect on radiation sensitivity. J Exp Med 112: 509-531, 1960
17. Erickson R, Szybalski W: Molecular radiobiology of human cell lines. V. Comparative radiosensitizing properties of 5-halodeoxycytidines and 5-halodeoxyuridines. Radiat Res 20: 252-262, 1963
18. Sano S, Hoshino T, Hagai M: Radiosensitization of brain tumor cells with a thymidine analog (bromouridine). J Neurosurg 28: 530-538, 1968
19. Kinsella T, Collins J, Rowlan J, Klecker R, Wright D, Katz D, Steinberg S, Glatstein E: Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme. J Clin Oncol 6: 871-879, 1988
20. Goffinet DR, Brown JM: Comparison of intravenous and intra-arterial pyrimidine infusion as a means of radiosensitizing tumors. Radiology 124: 819-822, 1977
21. Russo A, Gianni L, Kinsella T, Klecker R, Jenkins J, Rowland J, Glatstein E, Mitchell M, Collins J, Myers C: Pharmacological evaluation of intravenous delivery of 5-bromodeoxyuridine to patients with brain tumors. Cancer Res 44: 702-1705, 1984
22. Jackson D, Kinsella TJ, Rowland J, Wright D, Katz D, Main D, Collins J, Kornblith P, Glatstein E: Halogenated pyrimidines as radiosensitizers in the treatment of glioblastoma multiforme. Am J Clin Oncol 10: 437-443, 1987
23. Kinsella T, Russo A, Mitchell J, Collins J, Rowland J, Wright D, Glatstein EA: Phase I study of intravenous iododeoxyuridine as a clinical radiosensitizer. Int J Radiat Oncol Biol Phys 11: 1941-1946, 1985
24. Kinsella T, Collins J, Rowlan J, Klecker R, Wright D, Katz D, Steinberg S, Glatstein E: Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme. J Clin Oncol 6: 871-879, 1988
25. Greenberg HS, Chandler WF, Ensminger WD: Radiosensitization with carotid arterial infusion bromodeoxyuridine and external beam radiation for gliomas. In: Ensminger WD, Selam JL (eds) Update in Drug Delivery Systems, Mount Kisco, NY, Futura Publishing Co., 233-246, 1989
26. Hegarty TJ, Thornton AF, Diaz RF, Chandler WF, Ensigner WD, Junck L, Page MA, Gebarski SS, Hood TW, Stetson PL, Tankanow RM, McKevver PE, Lichter AS, Greenberg HS: Intra-arterial bromodeoxyuridine radiosensitization of malignant gliomas. Int J Radiat Oncol, Biol Phys 19: 421-428, 1990
27. Wirtanen GW, Wiley AL, Vermund H, Stephenson JA, Ansfield FJ: Intraarterial iododeoxyuridine infusion combined with irradiation. A pilot study. Am J Clin Oncol 13(4): 320-323, 1990
28. Cook J, Glass J, Lebovics R, Bobo H, Pass H, Delaney T, Oldfield E, Mitchell J, Glatstein E, Goffman T: Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusion of 5-iododeoxyuridine. Cancer Res 52: 719-725, 1992
29. Goffman TE, Dachowsk LJ, Bobo H, Oldfield E, Cook J, Mitchell JB, Katz D, Smith R, Glatstein E: Long-term follow-up on national cancer institute phase I/II study of glioblastoma multiforme treated with iododeoxyuridine and hyperfractionated irradiation. J Clin Oncol 10(2): 264-268, 1992
30. Urtasun RC, Cosmatos D, DelRowe J, Kinsella TJ, Lester S, Wasserman T, Fulton DS: Iododeoxyuridine (IUdR) combined with radiation in the treatment of malignant glioma: A comparison of short versus long intravenous dose schedules (RTOG 86-12). Int J Radiat Oncol Biol Phys 27: 207-214, 1993
31. Pollay M, Roberts PA: Blood-brain barrier: A definition of normal and altered function. Neurosurgery 6: 675-685, 1980
32. Langer R, Wise D (eds): medical applications of controlled release. Boco Raton, Fla, CRC Press, 1986
33. Leong KW, D'Amore P, Marletta M, Langer R: Bioerodible polyanhydrides as drug-carrier matrices. II. Biocompatibility and chemical reactivity. J Biomed Mat Res 20: 51-64, 1986
34. Brem H, Mahaley S, Vick N, Black K, Schold C, Burger P, Friedman A, Ciric I, Eller T, Cozzens J, Kenealy J: Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas. J Neurosurg 74: 441-446, 1991
35. Brem H, Piantadosi S, Burger P, Walker M, Selker R, Vick N, Black K, Sisti M, Brem S, Mohr G: Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet 345(8956): 1008-1012, 1995
36. Domb A, Langer R: Polyanhydrides. I. Preparation of high molecular weight polyanhydrides. J Polymer Science 25: 3373-3386, 1987
37. Walter K, Cahan M, Gur A, Tyler B, Hilton J, Colvin O, Burger P, Domb A, Brem H: Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma. Cancer Res 54(8): 2207-2212, 1994
38. Dillehay L, Mayer R, Zhang Y, Song S, Shao Y, Mackensen B, Williams J: Use of bremstrahlung radiation to monitor Y-90 tumor and whole body activities during experimental radioimmunotherapy in mice. Cancer 73(3) (suppl): 945-950, 1994
39. Mayer R, Dillehay LE, Shao Y, Song S, Zhang Y, Bartholomew RM, Williams JR: A new method for determining dose rate distribution from radioimmunotherapy using radiochromic medium. Int J Radiat Oncol Biol Phys 28: 505-513, 1993
40. Williams JA, Klein JL, Wanek PM, Poggenburg KA, Wharam MD, Wessels BW, Order SE: Quantitative intercomparison of radiolabeled antibodies and external beam radiotherapy in the treatment of human glioma xenografts in vivo. Int J Radiat Oncol Biol Phys 24(1): 111-117, 1992
41. Glantz SA: Primer of biostatistics. Pergamon Press, New York, 1992
42. Marin LA, Smith CE, Langston M, Quashie D, Dillehay L: Response of glioblastoma cell lines to low dose rate irradiation. Int J Radiat Oncol Biol Phys 21: 397-402, 1991
43. McLaughlin PW, Mancini WR, Stetson PL, Greenberg HS, Nguyen N, Seabury H, Heidorn DB, Lawrence TS: Halogenated pyrimidine sensitization of low dose rate irradiation in human malignant glioma. Int J Radiat Oncol, Biol Phys 26: 637-642, 1993
44. McLaughlin PW, Mancini WR, Stetson PL, Greenberg HS, Nguyen N, Seabury H, Heidorn DB, Lawrence TS: Halogenated pyrimidine sensitization of low dose rate irradiation in human malignant glioma. Int J Radiat Oncol, Biol Phys 26: 637-642, 1993
45. Tamada J, Langer R: Erosion kinetics of hydrolytically degradable polymers. Proc Natl Acad Sci USA 90: 552-556, 1993
46. Tabata Y, Domb A, Langer R: Injectable polyanhydride granules provide controlled release of water-soluble drugs with a reduced initial burst. J Pharm Sci 83: 5-11, 1994
47. Tamada J, Langer R: The development of polyanhydrides for drug delivery applications. J Biomater Sci Polymer Edn 3(4): 315-353, 1992
48. McLaughlin PW, Lawrence TS, Seabury H, Nguyen N, Stetson PL, Greenberg HS, Mancini WR: Bromodeoxyuridine-mediated radiosensitization in human glioma: the effect of concentration, duration, and fluoropyrimidine modulation. Int J Radiat Oncol Biol Phys 30(3): 601-607, 1994
49. Leong KW, Brott BC, Langer R: Bioerodible polyanhydrides as drug-carrier matrices. I. Characterization, degradation, and release characteristics. J Biomed Mater Res 19: 941-955, 1985
50. Tjuvajev J, Muraki A, Ginos J, Berk J, Koutcher J, Ballon D, Beattie B, Finn R, Blasberg R: Iododeoxyuridine uptake and retention as measure of tumor growth. J Nucl Med 34 (7): 1152-1162, 1993
51. Williams JA, Klein JL, Wanek PM, Poggenburg KA, Wharam MD, Wessels BW, Order SE: Quantitative intercomparison of radiolabeled antibodies and external beam radiotherapy in the treatment of human glioma xenografts in vivo. Int J Radiat Oncol Biol Phys 24(1): 111-117, 1992